Literature DB >> 20146113

Inhibitors and facilitators of willingness to participate (WTP) in an HIV vaccine trial: construction and initial validation of the Inhibitors and Facilitators of Willingness to Participate Scale (WPS) among women at risk for HIV infection.

Dylan Fincham1, Ashraf Kagee, Leslie Swartz.   

Abstract

A psychometric scale assessing inhibitors and facilitators of willingness to participate (WTP) in an HIV vaccine trial has not yet been developed. This study aimed to construct and derive the exploratory factor structure of such a scale. The 35-item Inhibitors and Facilitators of Willingness to Participate Scale (WPS) was developed and administered to a convenience sample of 264 Black females between the ages of 16 and 49 years living in an urban-informal settlement near Cape Town. The subscales of the WPS demonstrated good internal consistency with Cronbach's alpha coefficients ranging between 0.69 and 0.82. A principal components exploratory factor analysis revealed the presence of five latent factors. The factors, which accounted for 45.93% of the variance in WTP, were (1) personal costs, (2) safety and convenience, (3) stigmatisation, (4) personal gains and (5) social approval and trust. Against the backdrop of the study limitations, these results provide initial support for the reliability and construct validity of the WPS among the most eligible trial participants in the Western Cape of South Africa.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20146113     DOI: 10.1080/09540120903202939

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  7 in total

1.  Factors influencing mothers' decision to enroll their HIV-negative children in a hypothetical HIV vaccine trial.

Authors:  Victoria Williamson; Bronwyne Coetzee; Ashraf Kagee; Mark Tomlinson
Journal:  Future Virol       Date:  2016-12-21       Impact factor: 1.831

2.  Willingness to participate in trials and to be vaccinated with new tuberculosis vaccines in HIV-infected adults.

Authors:  T Kufa; V Chihota; S Charalambous; S Verver; G Churchyard
Journal:  Public Health Action       Date:  2013-03-21

3.  Characteristics of female sex workers in southern India willing and unwilling to participate in a placebo gel trial.

Authors:  Barbara S Mensch; Barbara A Friedland; Sharon A Abbott; Lauren L Katzen; Waimar Tun; Christine A Kelly; Avina Sarna; Aylur K Srikrishnan; Suniti Solomon
Journal:  AIDS Behav       Date:  2013-02

4.  Uptake of genital mucosal sampling in HVTN 097, a phase 1b HIV vaccine trial in South Africa.

Authors:  Erica Maxine Lazarus; Kennedy Otwombe; Tania Adonis; Elaine Sebastian; Glenda Gray; Nicole Grunenberg; Surita Roux; Gavin Churchyard; Craig Innes; Fatima Laher
Journal:  PLoS One       Date:  2014-11-17       Impact factor: 3.240

5.  "Why Don't You Go Into Suburbs? Why Are You Targeting Us?": Trust and Mistrust in HIV Vaccine Trials in South Africa.

Authors:  Siyabonga Thabethe; Catherine Slack; Graham Lindegger; Abigail Wilkinson; Douglas Wassenaar; Philippa Kerr; Linda-Gail Bekker; Kathy Mngadi; Peter A Newman
Journal:  J Empir Res Hum Res Ethics       Date:  2018-12       Impact factor: 1.742

6.  The willingness to participate in biomedical research involving human beings in low- and middle-income countries: a systematic review.

Authors:  Joyce L Browne; Connie O Rees; Johannes J M van Delden; Irene Agyepong; Diederick E Grobbee; Ama Edwin; Kerstin Klipstein-Grobusch; Rieke van der Graaf
Journal:  Trop Med Int Health       Date:  2019-01-08       Impact factor: 2.622

7.  Willingness to participate in HIV vaccine efficacy trials among high risk men and women from fishing communities along Lake Victoria in Uganda.

Authors:  Gershim Asiki; Andrew Abaasa; Eugene Ruzagira; Freddie Kibengo; Ubaldo Bahemuka; Jerry Mulondo; Janet Seeley; Linda-Gail Bekker; Sinead Delany; Pontiano Kaleebu; Anatoli Kamali
Journal:  Vaccine       Date:  2013-09-07       Impact factor: 3.641

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.